Thromboelastography Analyzer Market Report 2026

Thromboelastography Analyzer Market Overview

• Thromboelastography Analyzer market size has reached to $0.41 billion in 2025 • Expected to grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 11.5% • Growth Driver: Rising Trauma And Emergency Care Cases Fueling The Growth Of The Market Due To Increasing Need For Rapid Coagulation Assessment • Market Trend: Innovation In Viscoelastic Testing Systems Enhances Rapid And Comprehensive Coagulation Assessment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Thromboelastography Analyzer Market?

A thromboelastography analyzer is a medical diagnostic device that assesses the coagulation properties of a patient’s blood in real time. It helps to provide a comprehensive evaluation of clot formation, strength, and stability, helping clinicians guide transfusions and manage bleeding or thrombotic disorders. The analyzer measures clotting kinetics using viscoelastic methods, offering detailed insights into platelet function, fibrinogen activity, and overall hemostatic status. The main types of thromboelastography analyzers include single and double channel, four channels, and other types. Single and double channel analyzers refer to devices designed to measure the viscoelastic properties of blood in one or two simultaneous channels, providing rapid and accurate coagulation assessment. These analyzers use consumables or accessories such as disposable test cartridges, reagent kits, sample cups, pipettes, quality control materials, blood collection tubes, and analyzer accessories and cables. They utilize technologies including conventional thromboelastography, rotational thromboelastometry, and other viscoelastic hemostatic assay technologies. The multiple applications involved are cardiovascular surgery, trauma and emergency care, transplant surgery, obstetrics and gynecology, and liver and hematologic disorders and are used by several end users such as hospitals and surgical centers, diagnostic laboratories, maternal and child health services, and other end users.

What Is The Thromboelastography Analyzer Market Growth Forecast?

The thromboelastography analyzer market size is expected to see rapid growth in the next few years. It will grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to growing demand for personalized medicine approaches, rising investment in advanced diagnostic technologies, increasing geriatric population, expansion of critical care facilities, demand for rapid bedside testing solutions. Major trends in the forecast period include rising adoption of point of care coagulation testing, growth in multi-channel high throughput analyzers, increasing demand for surgical and trauma hemostasis monitoring, expansion of disposable reagents and consumables usage, integration of comprehensive blood clotting assessment in critical care.

Global Thromboelastography Analyzer Market Segmentation

1) By Type: Single And Double Channel, Four Channels, Other Types 2) By Consumables Or Accessories: Disposable Test Cartridges, Reagent Kits, Sample Cups, Pipettes, Quality Control Materials, Blood Collection Tubes, Analyzer Accessories And Cables 3) By Technology: Conventional Thromboelastography (TEG), Rotational Thromboelastometry (ROTEM), Other Viscoelastic Hemostatic Assay (VHA) Technologies 4) By Application: Cardiovascular Surgery, Trauma And Emergency Care, Transplant Surgery, Obstetrics And Gynecology, Liver And Hematologic Disorders 5) By End-User: Hospitals And Surgical Centers, Diagnostic Laboratories, Maternal And Child Health Services, Other End-Users Subsegments: 1) By Single And Double Channel: Single Sample Analysis, Dual Sample Analysis, Routine Coagulation Testing, Point Of Care Usage 2) By Four Channels: Multi Sample Parallel Analysis, High Throughput Testing, Advanced Clinical Diagnostics, Critical Care Monitoring 3) By Other Types: Portable Thromboelastography Systems, Research Oriented Systems, Customized Diagnostic Configurations

What Are The Drivers Of The Thromboelastography Analyzer Market?

The growing prevalence of trauma and emergency care cases is expected to propel the growth of thromboelastography analyzer market going forward. Trauma and emergency care cases refer to acute medical situations involving severe injuries or sudden life-threatening conditions that require immediate medical intervention to prevent death or long-term disability. Trauma and emergency care cases are increasing due to factors such as rising road traffic accidents. Rising road traffic accidents are driving demand for thromboelastography analyzers, as these devices enable rapid assessment of coagulation status in trauma patients, supporting timely bleeding management and improving emergency care outcomes. For instance, in September 2025, according to National Health Services, a UK-based government health agency, in 2024-25 there were 27.4 million attendances in accident and emergency, an increase of 4.0% compared with 2023-24. Therefore, the growing prevalence of trauma and emergency care cases is driving the growth of the thromboelastography analyzer industry. The Increasing number of surgical procedures is expected to propel the growth of the thromboelastography analyzer market going forward. The increasing number of surgical procedures refers to the rising volume of elective, emergency, and minimally invasive operations performed to diagnose, treat, or manage medical conditions. Surgical volumes are increasing as aging populations are raising the prevalence of chronic diseases that require operative intervention. Thromboelastography analyzer supports the increasing number of surgical procedures by enabling real-time coagulation assessment, which helps clinicians control bleeding risk and optimize transfusion decisions during complex and high-volume surgeries. For instance, in May 2024, according to NHS England, a UK-based public health authority, elective surgical admissions increased from $0.0169 billion in 2022–2023 to $0.0171 billion in 2023–2024, reflecting sustained growth in surgical activity across the national healthcare system. Therefore, the increasing number of surgical procedures is driving the growth of the thromboelastography analyzer industry.

Key Players In The Global Thromboelastography Analyzer Market

Major companies operating in the thromboelastography analyzer market are Medtronic plc, Werfen SA, Haemonetics Corporation, Lepu Medical Technology (Beijing) Co. Ltd, Helena Laboratories Corporation, Zircon Corp., Diagnostica Stago Inc., Hemosonics LLC, Chongqing Nanfang Instruments Co. Ltd., Medcaptain Medical Technology Co. Ltd., Render Biotech Co. Ltd., Sienco Inc., Framer Hemologix-Srl, Biomart Inc., Guizhou Jinjiu Biotech Co. Ltd., Xenometrix AG, Zhejiang Shengyu Medical Instrument Co. Ltd., Beijing WITEYE Biotechnology Co. Ltd., UD-BIO, Beijing Succeeder Technology Inc., Sycomed E.K.

Global Thromboelastography Analyzer Market Trends and Insights

Major companies operating in the thromboelastography analyzer market are focusing on developing innovative products, such as extended-use assay cartridges for viscoelastic testing systems to enable broader clinical application and faster, more comprehensive coagulation profiling across diverse patient groups. Extended-use assay cartridges for viscoelastic testing systems refer to consumable testing modules designed to expand the diagnostic capabilities of thromboelastography analyzers by catering to specific clinical conditions and patient cohorts. For instance, in April 2024, Haemonetics Corporation, a US-based provider of medical technologies and solutions for blood management, announced the U.S. Food and Drug Administration (FDA) approval for its TEG 6s Global Hemostasis. This new cartridge received FDA 510(k) clearance to extend the system’s viscoelastic testing capabilities to fully heparinized patients undergoing adult cardiovascular surgeries and liver transplantation, enhancing its use in both laboratory and point-of-care settings. The Global Hemostasis-HN cartridge provides clinicians with comprehensive insights into a patient’s coagulation profile faster and with greater detail than conventional tests, supported by software that enables remote real-time result viewing and customizable alerts. This innovation helps clinicians make more informed treatment decisions in critical care scenarios where rapid, accurate hemostasis assessment is essential.

Regional Outlook

North America was the largest region in the thromboelastography analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thromboelastography Analyzer Market?

The thromboelastography analyzer market consists of sales of thromboelastography analyzers, viscoelastic coagulation testing systems, point-of-care hemostasis analyzers, laboratory-based thromboelastography (TEG) instruments, and thromboelastography (TEG) reagents and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Thromboelastography Analyzer Market Report 2026?

The thromboelastography analyzer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thromboelastography analyzer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.